Dear Diary,
I've been working a new job recently, and it's keeping my full focus.
I sold HRB on May 22, 2009 for $13.98 a share, a loss from the $15.85 a share purchase price on April 21, 2009, due to a projected narrowing in the Net Profit Margin in the "Value Line" presentation. The loss was minimal and is balanced out with gains in MDT.
PDCO was sold on May 30, 2009 for $20.68 a share, based on the same narrowing of the Net Profit Margin. The average purchase price had been $19.24 a share, making a slight gain on the deal.
SYK was also sold on May 30, 2009 on the same basis for $38.95 a share. Purchase had been for $33.22 a share, another slight gain.
Note how Holy Grail protects the investor from substantial loss, while making money more often than not.
On the Cash on Sale Arbitrage front, I took a substantial position in JAVA, due to be sold for all cash to ORCL on August 6, 2009. I bought in for $9.0477 a share and will let the deal close naturally at $9.50 a share, a 25% annualized gain.
Gene